ReviewFrontiers in immunology2025

Harnessing delta-like ligand 3: bridging biomarker discovery to next-generation immunotherapies in refractory small cell lung cancer.

Kangkang Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.